Asia Spotlight: China Eclipses Japan To Become Second Largest Pharma Market
Executive Summary
Despite a slowdown, China’s pharma market passed Japan in 2013, two years faster than expected.
You may also be interested in...
China Eclipses Japan To Become Second Largest Pharma Market
Despite a slowdown, China’s pharma market passed Japan in 2013, two years faster than expected.
Samsung, Merck Look To Take On Sanofi’s Lantus With Latest Deal
In the latest win for Samsung Bioepis, the Korean company will help develop and manufacture a late-stage insulin glargine candidate with Merck.
Emerging Markets Earnings Roundup: GSK, AbbVie, Novo Nordisk (Part 5)
GSK reported that China pharmaceutical and vaccines sales were down 29% in Q4 and 18% for full year 2013, but CEO Andrew Witty tried to assure investors that sales are stabilizing. AbbVie chugs along on Humira and Novo Nordisk warns that emerging markets currency volatility may hit launch plans.